These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
761 related items for PubMed ID: 30293531
1. Vaccination with chemically attenuated Plasmodium falciparum asexual blood-stage parasites induces parasite-specific cellular immune responses in malaria-naïve volunteers: a pilot study. Stanisic DI, Fink J, Mayer J, Coghill S, Gore L, Liu XQ, El-Deeb I, Rodriguez IB, Powell J, Willemsen NM, De SL, Ho MF, Hoffman SL, Gerrard J, Good MF. BMC Med; 2018 Oct 08; 16(1):184. PubMed ID: 30293531 [Abstract] [Full Text] [Related]
2. Persistence and immunogenicity of chemically attenuated blood stage Plasmodium falciparum in Aotus monkeys. De SL, Stanisic DI, van Breda K, Bellete B, Harris I, McCallum F, Edstein MD, Good MF. Int J Parasitol; 2016 Aug 08; 46(9):581-91. PubMed ID: 27238088 [Abstract] [Full Text] [Related]
3. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection. Lyke KE, Ishizuka AS, Berry AA, Chakravarty S, DeZure A, Enama ME, James ER, Billingsley PF, Gunasekera A, Manoj A, Li M, Ruben AJ, Li T, Eappen AG, Stafford RE, Kc N, Murshedkar T, Mendoza FH, Gordon IJ, Zephir KL, Holman LA, Plummer SH, Hendel CS, Novik L, Costner PJ, Saunders JG, Berkowitz NM, Flynn BJ, Nason MC, Garver LS, Laurens MB, Plowe CV, Richie TL, Graham BS, Roederer M, Sim BK, Ledgerwood JE, Hoffman SL, Seder RA. Proc Natl Acad Sci U S A; 2017 Mar 07; 114(10):2711-2716. PubMed ID: 28223498 [Abstract] [Full Text] [Related]
4. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites. Bergmann ES, Ballou RW, Krzych U. Cell Immunol; 1997 Sep 15; 180(2):143-52. PubMed ID: 9341744 [Abstract] [Full Text] [Related]
5. Development and Evaluation of a Cryopreserved Whole-Parasite Vaccine in a Rodent Model of Blood-Stage Malaria. Stanisic DI, Ho MF, Nevagi R, Cooper E, Walton M, Islam MT, Hussein WM, Skwarczynski M, Toth I, Good MF. mBio; 2021 Oct 26; 12(5):e0265721. PubMed ID: 34663097 [Abstract] [Full Text] [Related]
6. A step forward for an attenuated blood-stage malaria vaccine. Burns JM. BMC Med; 2018 Nov 09; 16(1):204. PubMed ID: 30409141 [Abstract] [Full Text] [Related]
7. First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers. Spring M, Murphy J, Nielsen R, Dowler M, Bennett JW, Zarling S, Williams J, de la Vega P, Ware L, Komisar J, Polhemus M, Richie TL, Epstein J, Tamminga C, Chuang I, Richie N, O'Neil M, Heppner DG, Healer J, O'Neill M, Smithers H, Finney OC, Mikolajczak SA, Wang R, Cowman A, Ockenhouse C, Krzych U, Kappe SH. Vaccine; 2013 Oct 09; 31(43):4975-83. PubMed ID: 24029408 [Abstract] [Full Text] [Related]
8. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Mordmüller B, Surat G, Lagler H, Chakravarty S, Ishizuka AS, Lalremruata A, Gmeiner M, Campo JJ, Esen M, Ruben AJ, Held J, Calle CL, Mengue JB, Gebru T, Ibáñez J, Sulyok M, James ER, Billingsley PF, Natasha KC, Manoj A, Murshedkar T, Gunasekera A, Eappen AG, Li T, Stafford RE, Li M, Felgner PL, Seder RA, Richie TL, Sim BK, Hoffman SL, Kremsner PG. Nature; 2017 Feb 23; 542(7642):445-449. PubMed ID: 28199305 [Abstract] [Full Text] [Related]
9. Chemically Attenuated Blood-Stage Plasmodium yoelii Parasites Induce Long-Lived and Strain-Transcending Protection. Raja AI, Cai Y, Reiman JM, Groves P, Chakravarty S, McPhun V, Doolan DL, Cockburn I, Hoffman SL, Stanisic DI, Good MF. Infect Immun; 2016 Aug 23; 84(8):2274-2288. PubMed ID: 27245410 [Abstract] [Full Text] [Related]
10. Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses. Powell TJ, Tang J, Derome ME, Mitchell RA, Jacobs A, Deng Y, Palath N, Cardenas E, Boyd JG, Nardin E. Vaccine; 2013 Apr 08; 31(15):1898-904. PubMed ID: 23481177 [Abstract] [Full Text] [Related]
11. Controlled Human Malaria Infection of Healthy Adults With Lifelong Malaria Exposure to Assess Safety, Immunogenicity, and Efficacy of the Asexual Blood Stage Malaria Vaccine Candidate GMZ2. Dejon-Agobe JC, Ateba-Ngoa U, Lalremruata A, Homoet A, Engelhorn J, Nouatin OP, Edoa JR, Fernandes JF, Esen M, Mouwenda YD, Betouke Ongwe EM, Massinga-Loembe M, Hoffman SL, Sim BKL, Theisen M, Kremsner PG, Adegnika AA, Lell B, Mordmüller B. Clin Infect Dis; 2019 Sep 27; 69(8):1377-1384. PubMed ID: 30561539 [Abstract] [Full Text] [Related]
12. The march toward malaria vaccines. Hoffman SL, Vekemans J, Richie TL, Duffy PE. Vaccine; 2015 Nov 27; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116 [Abstract] [Full Text] [Related]
13. Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines. Draper SJ, Biswas S, Spencer AJ, Remarque EJ, Capone S, Naddeo M, Dicks MD, Faber BW, de Cassan SC, Folgori A, Nicosia A, Gilbert SC, Hill AV. J Immunol; 2010 Dec 15; 185(12):7583-95. PubMed ID: 21098232 [Abstract] [Full Text] [Related]
14. The species specificity of immunity generated by live whole organism immunisation with erythrocytic and pre-erythrocytic stages of rodent malaria parasites and implications for vaccine development. Inoue M, Tang J, Miyakoda M, Kaneko O, Yui K, Culleton R. Int J Parasitol; 2012 Aug 15; 42(9):859-70. PubMed ID: 22846785 [Abstract] [Full Text] [Related]
15. Complete attenuation of genetically engineered Plasmodium falciparum sporozoites in human subjects. Kublin JG, Mikolajczak SA, Sack BK, Fishbaugher ME, Seilie A, Shelton L, VonGoedert T, Firat M, Magee S, Fritzen E, Betz W, Kain HS, Dankwa DA, Steel RW, Vaughan AM, Noah Sather D, Murphy SC, Kappe SH. Sci Transl Med; 2017 Jan 04; 9(371):. PubMed ID: 28053159 [Abstract] [Full Text] [Related]
16. A genetically engineered Plasmodium falciparum parasite vaccine provides protection from controlled human malaria infection. Murphy SC, Vaughan AM, Kublin JG, Fishbauger M, Seilie AM, Cruz KP, Mankowski T, Firat M, Magee S, Betz W, Kain H, Camargo N, Haile MT, Armstrong J, Fritzen E, Hertoghs N, Kumar S, Sather DN, Pinder LF, Deye GA, Galbiati S, Geber C, Butts J, Jackson LA, Kappe SHI. Sci Transl Med; 2022 Aug 24; 14(659):eabn9709. PubMed ID: 36001680 [Abstract] [Full Text] [Related]
17. Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies. Zenklusen I, Jongo S, Abdulla S, Ramadhani K, Lee Sim BK, Cardamone H, Flannery EL, Nguyen T, Fishbaugher M, Steel RWJ, Betz W, Carmago N, Mikolajczak S, Kappe SHI, Hoffman SL, Sack BK, Daubenberger C. J Infect Dis; 2018 Apr 23; 217(10):1569-1578. PubMed ID: 29438525 [Abstract] [Full Text] [Related]
18. Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys. Egan AF, Blackman MJ, Kaslow DC. Infect Immun; 2000 Mar 23; 68(3):1418-27. PubMed ID: 10678955 [Abstract] [Full Text] [Related]
19. Antibody and T-cell responses associated with experimental human malaria infection or vaccination show limited relationships. Walker KM, Okitsu S, Porter DW, Duncan C, Amacker M, Pluschke G, Cavanagh DR, Hill AV, Todryk SM. Immunology; 2015 May 23; 145(1):71-81. PubMed ID: 25471322 [Abstract] [Full Text] [Related]
20. Malaria vaccine trials: the missing qualitative data. Ferreira M. Immunol Cell Biol; 1996 Aug 23; 74(4):301-5. PubMed ID: 8872178 [Abstract] [Full Text] [Related] Page: [Next] [New Search]